Convergence Ventures

Convergence Ventures is a Jakarta-based early-stage tech fund deploying $250k-$5M cheques at pre-seed, seed, and Series A into Indonesia’s digital and technology ecosystem, including digital health. The firm has been an active participant in Indonesian venture across multiple vintages and operates with a generalist tech thesis with selective health-tech bets. For founders, Convergence is best positioned as a domestic Indonesian anchor that can lead seed rounds and bridge to regional Series A leads. The right founder profile is an Indonesian operator building a digital health, telemedicine, or health IT platform with early traction, regulatory awareness, and a credible plan to expand within Indonesia and selectively across Southeast Asia. Founders running deep biotech, asset-heavy hospital networks, or non-Indonesian plays without local presence are a poor fit. Entry path is via a Convergence portfolio CEO, the Jakarta founder community, or warm introductions from co-investing regional funds (East Ventures, Insignia, Vertex, AC Ventures). In the pitch, lead with concrete unit economics in IDR with FX-aware forecasting, regulatory navigation through BPOM and MOH, hospital or insurer partnerships, and a credible Series A narrative that names likely regional leads. Caveats: AI focus is not stated and the firm is not branded as an AI specialist, so AI-heavy founders should bring external technical advisors. Indonesian healthcare regulatory navigation and provider digitisation are uneven, so any clinical AI or digital health play must be backed by integration evidence rather than abstract product claims. Follow-on capital depth at Series B and beyond depends on regional and international leads, so plan syndication early. Public deal cadence has varied across vintages, so request a recent deal sheet during initial diligence to verify pacing and reserves policy.